Stock ELYM ELIEM THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Eliem Therapeutics, Inc.

Equities

ELYM

US28658R1068

Real-time Estimate Cboe BZX
Other stock markets
 02:14:21 2024-05-28 pm EDT 		5-day change 1st Jan Change
7.455 USD +0.61% Intraday chart for Eliem Therapeutics, Inc. -4.91% +176.11%
May. 15 Eliem Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 11 Sector Update: Health Care Stocks Softer Late Afternoon MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Downgrades Eliem Therapeutics to Neutral From Buy
MT
HC Wainwright Starts Eliem Therapeutics at Buy With $6 Price Target
MT
SVB Securities Adjusts Eliem Therapeutics' Price Target to $4 From $9, Keeps Outperform Rating
MT
SVB Securities Adjusts Eliem Therapeutics' Price Target to $9 from $13, Keeps Outperform Rating
MT
Guggenheim Downgrades Eliem Therapeutics to Neutral from Buy
MT
SVB Leerink Lowers Price Target for Eliem Therapeutics to $13 From $33, Maintains Outperform Rating
MT
ELIEM THERAPEUTICS : Evercore ISI Initiates Coverage on Eliem Therapeutics With Outperform Rating
MT
ELIEM THERAPEUTICS : Stifel Starts Eliem Therapeutics at Buy with $35 Price Target
MT
ELIEM THERAPEUTICS : SVB Leerink Starts Eliem Therapeutics at Outperform with $33 Price Target
MT
ELIEM THERAPEUTICS : Guggenheim Starts Eliem Therapeutics at Buy with $32 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ELYM Stock
  4. News Eliem Therapeutics, Inc.
  5. Analyst Reco.